Resultado de búsqueda
In 1969, he founded Biotrics, Inc. and in 1981, he co-founded Biomatrix, Inc., where he as Chief Executive Officer and Chief Scientific Officer further expanded the medical applications of the substance. In 1999, Biomatrix was recognized by Fortune as one of the fastest growing companies in the US. In 2000, Biomatrix was sold to Genzyme, Inc.
Endre BALAZS, Chairman of The Board and Chief Scientific Officer | Cited by 5,742 | of Matrix Biology Institute, Edgewater (MATRIXBIOINST) | Read 104 publications | Contact Endre BALAZS
4 de sept. de 2015 · Dr. Balazs transformed a syrupy natural substance from rooster combs into a palliative for arthritis and a skin protectant that made eye surgery routine.
Endre A. Balazs, MD distinguished himself through pioneering research on the structure and biological activity of hyaluronan, a viscoelastic polysaccharide present in all tissues of the human body, but in larger amounts in the vitreus of the eye and in the soft tissues of joints and skin.
25 de feb. de 2015 · The NYU Polytechnic School of Engineering is now the home of the Biomatrix Research Center, located in a new state-of-the-art facility in Manhattan’s Health Corridor. Thanks to a $4.5 million grant from the Endre A. Balazs Foundation, the Center houses a research group overseen by Mary Cowman, Associate Dean for Bioengineering and ...
The company, under Balazs’ leadership, developed new hyaluronan products for therapeutic use in the joint and skin, and for drug delivery and tissue augmentation. During the next 18 years, Biomatrix developed and marketed worldwide six hyaluronan products for various therapeutic uses.
29 de may. de 2000 · ENDRE A. BALAZS is Chief Executive Officer and Chief Scientific Officer of Biomatrix, Inc. and the Malcolm P. Aldrich Professor Emeritus of Ophthalmology at the Columbia...
